glp-1 different types Is Safe for Weight Loss? Peptides, Benefits & Risks Your guide to GLP-1 side

Studies are also underway for a spectrum of other conditions, including Phase 3 trials investigating non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and obstructive sleep apnea (OSA), as well as mid-to-late stage trials exploring potential benefits in neurodegenerative disorders like Parkinsons disease

Together with Ryan Livingston, we created a piece looking back at the 1-year implications of the GLP-1 antagonist for CKD and T2D, speaking with key experts from Cleveland Clinic and the American Heart Association, along with Holly Kramer from Loyola Medicine, Editor-in-Chief at Advances in Kidney Disease and Health (AKDH)

As this promising treatment for weight loss works toward FDA approval, it is not yet available via standard prescription

If you are pregnant or breastfeeding, do not take Zepbound (Tirzepatide) because it is not known if it will harm your unborn baby or pass into your breast milk